COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 87 filers reported holding COGENT BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,950,192 | +2.1% | 1,636,961 | +24.2% | 0.01% | 0.0% |
| Q2 2023 | $15,616,834 | -13.0% | 1,318,112 | -20.7% | 0.01% | -16.7% |
| Q1 2023 | $17,940,720 | -3.2% | 1,662,265 | +3.7% | 0.01% | -7.7% |
| Q4 2022 | $18,530,576 | -26.5% | 1,602,197 | -52.6% | 0.01% | -31.6% |
| Q3 2022 | $25,209,184 | +31.2% | 3,377,058 | +58.5% | 0.02% | +46.2% |
| Q2 2022 | $19,217,000 | -18.9% | 2,130,496 | -32.7% | 0.01% | +18.2% |
| Q1 2022 | $23,708,000 | +9.8% | 3,165,241 | +25.8% | 0.01% | +22.2% |
| Q4 2021 | $21,584,000 | +2.8% | 2,515,254 | +0.9% | 0.01% | 0.0% |
| Q3 2021 | $20,996,000 | +6.1% | 2,493,961 | +2.3% | 0.01% | +12.5% |
| Q2 2021 | $19,785,000 | -1.3% | 2,438,201 | +6.8% | 0.01% | -11.1% |
| Q1 2021 | $20,038,000 | +3.3% | 2,283,128 | +32.1% | 0.01% | 0.0% |
| Q4 2020 | $19,399,000 | – | 1,728,670 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,884,977 | $52,708,902 | 10.29% |
| COMMODORE CAPITAL LP | 4,772,421 | $51,494,423 | 7.84% |
| TCG Crossover Management, LLC | 3,631,042 | $39,178,943 | 7.64% |
| Fairmount Funds Management LLC | 2,758,975 | $29,769,340 | 5.12% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5,411,509 | 4.47% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 579,264 | $6,250,259 | 2.58% |
| 5AM Venture Management, LLC | 790,440 | $8,528,848 | 2.18% |
| Ghost Tree Capital, LLC | 550,000 | $5,935,000 | 1.75% |
| Frazier Life Sciences Management, L.P. | 2,159,154 | $23,297,272 | 1.69% |
| HighVista Strategies LLC | 183,984 | $1,985,187 | 1.62% |